The lead discovery center (ldc) was established in 2008 by the technology transfer organization max planck innovation, as a novel approach to capitalize on the potential of excellent basic research for the discovery of new therapies for diseases with high medical need.
LDC and AstraZeneca broaden Drug Discovery Alliance, Released:14/04/15The Lead Discovery Center GmbH (LDC) and AstraZeneca have expanded their alliance to discover new medicines for the treatment of human diseases with high unmet medical need. |
LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria, Released:01/04/15The Lead Discovery Center GmbH (LDC) and the Helmholtz Centre for Infection Research (HZI) will be working in close cooperation to identify and optimize new drug candidates against methicillin-resistant Staphylococcus aureus (MRSA). |
LDC Receives 1 Million Euros from the Max Planck Foundation, Released:10/03/15The Lead Discovery Center receives one million euros from the Max Planck Foundation for the development of new drug candidates. |
LDC and The Arctic University of Norway Collaborate to Discover New Medicines from the Arctic Ocean, Released:11/10/14The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and UiT The Arctic University of Norway (UiT) have teamed up to discover new medicines from the marine arctic environment. |
LDC Enters First Collaboration with the Helmholtz Association, Released:09/10/14New cancer therapy approach from the German Cancer Consortium (DKTK) |
LDC Forms Early Drug Discovery Alliance with Daiichi Sankyo, Released:17/04/14Utilizing shared compound libraries for novel LDC targets |
Anti-Cancer Program Originating from LDC Reaches Clinical Trials, Released:07/12/13First LDC-lead structure successfully progressed by Bayer Pharma AG into clinical study phase |
Lead Discovery Center GmbH Announces Five-year Strategic Partnership with Merck Serono, Released:31/10/13Partners will collaborate to discover lead structures and potential development candidates for novel drug targets |
Tel | 4923197427002 |
******************* | |
Website | http://www.lead-discovery.de/ |
Address | Otto-Hahn-Straße 15 |
Town | Dortmund |
Postcode | 44227 |
Country | Germany |
Add your logo | |
Add Linkable tags | |
Add products / services | |
Add press releases |
In just 5 minutes you could have your own free business profile. Click to get started
Add My Business